Itamar Medical Ltd, a publicly traded medical device company develops, manufactures, and markets diagnostic products based on its proprietary PAT™ (Peripheral Arterial Tone) technology that provides an innovative solution to diagnosing sleep-breathing disorders and cardiovascular conditions. Itamar’s FDA-cleared HST device, the WatchPAT, uses innovative technology to enable simple and accurate Obstructive Sleep Apnea (OSA) testing while avoiding the complexity and discomfort associated with traditional air-flow based systems. More information about Itamar Medical can be found online at www.itamar-medical.com.